Navigating Targeted Therapy Access: Innovations...

By João L. Carapinha

November 14, 2025

Evolving Landscape of Targeted Therapies and Access Challenges Expanding targeted therapy access remains a critical challenge amid the pharmaceutical market's shift towa...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
China Medical Research Challenges: Pushing Boundaries Amid Ethical and Qualit...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Aligning Medical Schemes with National Health Insurance South Africa
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...